Relationship between measures of inhibitory processes in patients with schizophrenia: Role of substance abuse disorders

Psychiatry Research

Volumn 190, Issue 2-3, 2011, Pages 187-192

  Jurado Barba, Rosa ^a,b   Morales Muñoz, Isabel ^a,c   del Manzano, Blanca Álvarez ^a   Fernández Guinea, Sara ^d   Caballero, Montserrat ^a   Martínez Gras, Isabel ^a,b   Rubio Valladolid, Gabriel ^a,b,c  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

^c SCHOOL OF MEDICINE   (Spain)

^d UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Inhibition; Prepulse inhibition; Schizophrenia; Stroop; Substance abuse; Wisconsin Card Sorting Test

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; COGNITION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE COURSE; DISEASE DURATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; POSITIVE AND NEGATIVE SYNDROME SCALE; PREPULSE INHIBITION; PRIORITY JOURNAL; SCHIZOPHRENIA; SOCIAL ADAPTATION; STARTLE REFLEX; STROOP TEST; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS; SUBSTANCE ABUSE; TOBACCO DEPENDENCE; WISCONSIN CARD SORTING TEST;

ACOUSTIC STIMULATION; ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; COGNITION DISORDERS; FEMALE; HUMANS; INHIBITION (PSYCHOLOGY); MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; STARTLE REACTION; STATISTICS AS TOPIC; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 82955203362     PISSN: 01651781     EISSN: 18727123     Source Type: Journal    
DOI: 10.1016/j.psychres.2011.06.002     Document Type: Article

References (69)

1. Addington J., Addington D. Substance abuse and cognitive functioning in schizophrenia. Journal of Psychiatry & Neuroscience 1997, 2:99-104.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, APA, Washington, DC.
3. Barr R.S., Culhane M.A., Jubelt L.E., Mufti R.S., Dyer M.A., Weiss A.P., Deckersbach T., Kelly J.F., Freudenreich O., Goff D.C., Evins A.E. The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls. Neuropsychopharmacology 2008, 33(3):480-490.
4. Bitsios P., Giakoumaki S.G. Relationship of prepulse inhibition of the startle reflex to attentional and executive mechanisms in man. International Journal of Psychophysiology 2005, 55(2):229-241.
5. Bleuler E. Dementia Praecox or the Group of Schizophrenia 1950, International Universities Press, New York.
6. Braff D.L., Freedman R., Schork N.J., Gottesman I.I. Deconstructing schizophrenia: an overview of the use of endophenotypes in order to understand a complex disorder. Schizophrenia Bulletin 2007, 33(1):21-32.
7. Braff D.L., Grillon C., Geyer M.A. Gating and habituation of the startle reflex in schizophrenic patients. Archives of General Psychiatry 1992, 49:206-215.
8. Brekke J., Kay D.D., Lee K.S., Green M.F. Biosocial pathways to functional outcome in schizophrenia. Schizophrenia Research 2005, 15:213-225.
9. Butler R.W., Jenkins M.A., Geyer M.A., Braff D.L. Wisconsin card sorting deficits and diminished sensorimotor gating in a discrete subgroup of schizophrenic patients. Advances in Neuropsychiatry and Psychopharmacology 1991, Raven Press, New York. C.A. Tamminga, S.C. Schulz (Eds.).
10. Carey K.B., Carey M.P., Simons J.S. Correlates of substance use disorder among psychiatric outpatients: focus on cognition, social role functioning, and psychiatric status. The Journal of Nervous and Mental Disease 2003, 191:300-308.
11. Cleghorn J.M., Kaplan R.D., Szechtman B., Szechtman H., Brown H.G., Franco S. Substance abuse and schizophrenia: effect on symptoms but not on neurocognitive function. The Journal of Clinical Psychiatry 1991, 52:26-30.
12. Dixon L., Haas G., Weiden P.J., Sweeney J., Frances A.J. Drug abuse in schizophrenic patients: clinical correlated and reasons for use. The American Journal of Psychiatry 1991, 148:224-230.
13. Eack S.M., Greenwald D.P., Hogarty S.S., Keshavan M.S. One-year durability of the effects of cognitive enhancement therapy on functional outcome in early schizophrenia. Schizophrenia Research 2010, 120:210-216.
14. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders - Patient Edition (SCID-I/P v.2) 1995, New York State Psychiatric Institute, Biometrics Research Department, New York.
15. Friedman N.P., Miyake A. The relations among inhibition and interference control functions: a latent-variable analysis. Journal of Experimental Psychology. General 2004, 133(1):101-135.
16. Gay P., Rochat L., Billieux J., d'Acremont M., Van der Linden M. Heterogeneous inhibition processes involved in different facets of self-reported impulsivity: evidence from a community sample. Acta Psychologica (Amst) 2008, 129(3):332-339.
17. George T.P., Termine A., Sacco K.A., Allen T.M., Reutenauer E., Vessicchio J.C., Duncan E.J. A preliminary study of the effects of cigarette smoking on prepulse inhibition in schizophrenia: involvement of nicotinic receptor mechanisms. Schizophrenia Research 2006, 87(1-3):307-315.
18. George T.P., Vessicchio J.C., Termine A., Sahady D.M., Head C.A., Pepper W.T., Kosten T.R., Wexler B.E. Effects of smoking abstinence on visuospatial working memory function in schizophrenia. Neuropsychopharmacology 2002, 26(1):75-85.
19. Golden C.J. Stroop: el test de Colores y Palabras 1995, TEA Ediciones, S.A., Madrid.
20. Graham F.K. The more or less startling effects of weak prestimulation. Psychophysiology 1975, 5:108-114.
21. Harnishfeger K.K. The development of cognitive inhibition: theories, definitions, and research evidence. Interference and Inhibition in Cognition 1995, Academic Press, New York. F.N. Dempster, C.J. Brainerd (Eds.).
22. Heatherton T.F., Kozlowski L.T., Frecker R.C., Fagerstrom K.O. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. British Journal of Addiction 1991, 86(9):1119-1127.
23. Heaton R.K., Chelune G.J., Talley J.L., Kay G.G., Curtiss G. Test de clasificación de cartas de Wisconsin 1996, TEA Ediciones, S.A., Madrid.
24. Horan W.P., Braff D.L., Nuechterlein K.H., Sugar C.A., Cadenhead K.S., Calkins M.E., Dobie D.J., Freedman R., Greenwood T.A., Gur R.E., Gur R.C., Light G.A., Mintz J., Olincy A., Radant A.D., Schork N.J., Seidman L.J., Siever L.J., Silverman J.M., Stone W.S., Swerdlow N.R., Tsuang D.W., Tsuang M.T., Turetsky B., Green M.F. Verbal working memory impairments in individuals with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia. Schizophrenia Research 2008, 103:218-228.
25. Joyal C.C., Hallé P., Lapierre D., Hodgins S. Drug abuse and/or dependence and better neuropsychological performance in patients with schizophrenia. Schizophrenia Research 2003, 63:297-299.
26. Karper L.P., Freeman G.K., Grillon C., Morgan C.A., Charney D.S., Krystal J.H. Preliminary evidence of an association between sensorimotor gating and distractibility in psychosis. The Journal of Neuropsychiatry and Clinical Neurosciences 1996, 8(1):60-66.
27. Kok A. Varieties of inhibition: manifestations in cognition, event-related potentials and aging. Acta Psychologica (Amst) 1999, 101(2-3):129-158.
28. Koren D., Harrison R.H., Kremen W.S., Goldstein J.M., Faraone S.V., Seidman L.J., Lyons M.J., Caplan B., Tsuang M.T. Factor structure of the Wisconsin Card Sorting Test: dimensions of deficit in schizophrenia. Neuropsychology 1998, 12(2):289-302.
29. Kosmidis M.H., Bozikas V.P., Zafiri M., Karavatos A. Shared cognitive processes underlying performance on the Wisconsin Card Sorting Test and the Stroop Test in patients with schizophrenia: a measurement artifact?. Neuroscience Letters 2006, 409(3):234-238.
30. Kumari V., Checkley S.A., Gray J.A. Effect of cigarette smoking on prepulse inhibition of the acoustic startle reflex in healthy male smokers. Psychopharmacology 1996, 128:54-60.
31. Kumari V., Sharma T. Effects of typical and atypical antipsychotics on prepulse inhibition in schizophrenia: a critical evaluation of current evidence and directions for future research. Psychopharmacology 2002, 162:97-101.
32. Kumari V., Soni W., Sharma T. Influence of cigarette smoking on the prepulse inhibition of the acoustic startle response in schizophrenia. Human Psychopharmacology 2001, 16:321-326.
33. Kurtz M.M., Moberg P.J., Gur R.C., Gur R.E. Approaches to cognitive remediation of neuropsychological deficits in schizophrenia: a review and meta-analysis. Neuropsychology Review 2001, 11(4):197-210.
34. Kurzban S., Davis L., Brekke J.S. Vocational, social, and cognitive rehabilitation for individuals diagnosed with schizophrenia: a review of recent research and trends. Current Psychiatry Reports 2010, 12:345-355.
35. Lundqvist T. Cognitive consequences of cannabis use: comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions. Pharmacology Biochemistry and Behavior 2005, 81:319-330.
36. Marín M., Koeneke A., López J., Curivil P., Martínez I., Ponce G., Rodriguez-Jiménez R., Rubio G. Impairment in the prepulse inhibition (PPI) in abstinent alcoholics. Presented at conference, "9th World Congress of Biological Psychiatry." 28 June-2 July 2009 Paris, France 2009.
37. Martinez-Gras I., Rubio G., del Manzano B.A., Rodriguez-Jimenez R., Garcia-Sanchez F., Bagney A., Leza J.C., Borrell J. The relationship between prepulse inhibition and general psychopathology in patients with schizophrenia treated with long-acting risperidone. Schizophrenia Research 2009, 115(2-3):215-221.
38. McCleery A., Addington J., Addington D. Substance misuse and cognitive functioning in early psychosis: a 2year follow-up. Schizophrenia Research 2006, 88:187-191.
39. Miyake A., Friedman N.P., Emerson M.J., Witzki A.H., Howerter A., Wager T.D. The unity and diversity of executive functions and their contributions to complex "Frontal Lobe" tasks: a latent variable analysis. Cognitive Psychology 2000, 41(1):49-100.
40. Nigg J.T. On inhibition/disinhibition in developmental psychopathology: views from cognitive and personality psychology and a working inhibition taxonomy. Psychological Bulletin 2000, 126(2):220-246.
41. Nixon S.J., Hallford G.H., Tivis R.D. Neurocognitive function in alcoholic, schizophrenic, and dually diagnosed patients. Psychiatry Research 1996, 64:35-45.
42. Attention to action: willed and automatic control of behaviour. Center for Human Information Processing 1999, Plenum Press, New York. D.A. Norman, T. Shallice (Eds.).
43. Penadés R., Catalán R., Puig O., Masana G., Pujol N., Navarro V., Guarch J., Gastó C. Executive function needs to be targeted to improve social functioning with Cognitive Remediation Therapy (CRT) in schizophrenia. Psychiatry Research 2010, 177:41-45.
44. Pencer A., Addington J. Substance use and cognition in early psychosis. Journal of Psychiatry & Neuroscience 2003, 8:48-54.
45. Perry W., Braff D.L. Information processing deficits and thought disorders in patients with eschizophrenia. The American Journal of Psychiatry 1994, 151(3):363-367.
46. Perry W., Feifel D., Minassian A., Bhattacharjie I., Braff D.L. Information processing deficits in acutely psychotic schizophrenia patients medicated and unmedicated at the time of admission. The American Journal of Psychiatry 2002, 159:1375-1381.
47. Picciotto M.R., Caldarone B.J., King S.L., Zachariou V. Nicotinic receptors in the brain. Links between molecular biology and behavior. Neuropsychopharmacology 2000, 22:451-465.
48. Rabin R.A., Sacco K.A., George T.P. Correlation of prepulse inhibition and Wisconsin Card Sorting Test in schizophrenia and controls: effects of smoking status. Schizophrenia Research 2009, 114(1-3):91-97.
49. Rodriguez-Jiménez R., Bagney A., Martínez-Gras I., Ponce G., Sánchez-Morla E.M., Aragües M., Rubio G., Jiménez-Arriero M.A., Santos J.L., Palomo T., PARG Executive function in schizophrenia: influence of substance use disorder history. Schizophrenia Research 2009, 118(1-3):34-40.
50. Rogers R.D., Robbins T.W. Investigating the neurocognitive deficits associated with chronic drug misuse. Current Opinion in Neurobiology 2001, 11:250-257.
51. Sacco K.A., Termine A., Dudas M.M., Seyal A.A., Allen T.M., Vessicchio J.C., Wexler B.E., George T.P. Neuropsychological deficits in nonsmokers with schizophrenia: effects of a nicotinic antagonist. Schizophrenia Research 2006, 85(1-3):213-221.
52. Scheurich A. Neuropsychological functioning and alcohol dependence. Current Opinion in Neurobiology 2005, 18:319-323.
53. Serper M.R., Bergman A., Copersino M.L., Chou J.C.Y., Richarme D., Cranco R. Learning and memory impairment in cocaine dependent and comorbid schizophrenic patients. Psychiatry Research 2000, 93:21-32.
54. Serper M.R., Copersino M.L., Richarme D., Vadhan N., Cranco R. Neurocognitive functioning in recently abstinent, cocaine abusing schizophrenic patients. Journal of Substance Abuse 2000, 11:205-213.
55. Sevy S., Kay S.R., Opler L., van Praag H.M. Significance of cocaine history in schizophrenia. The Journal of Nervous and Mental Disease 1990, 178:642-648.
56. Sevy S., Robinson D.G., Holloway S., Alvir J.M., Woerner M.G., Bilder R., Goldman R., Lieberman J., Kane J. Correlates of substance misuse in patients with first-episode schizophrenia and schizoaffective disorder. Acta Psychiatrica Scandinavica 2001, 104:367-374.
57. Spiga S., Lintas A., Diana M. Addiction and cognitive functions. Annals of the New York Academy of Sciences 2008, 1139:299-306.
58. Swerdlow N.R., Light G.A., Cadenhead K.S., Sprok J., Braff D.L. Startle gating deficits in a large cohort of patients with schizophrenia. Archives of General Psychiatry 2006, 63:1325-1335.
59. Tirapu-Ustárroz J., Luna-Lario P. Neuropsicología de las funciones ejecutivas. Manual de Neuropsicología 2008, Viguera Editores, S.L., Barcelona. J. Tirapu-Ustárroz, M. Rios Lagos, F. Maestú Unturbe (Eds.).
60. Verbruggen F., Liefooghe B., Vandierendonck A. The interaction between stop signal inhibition and distractor interference in the flanker and Stroop task. Acta Psychologica (Amst) 2004, 116(1):21-37.
61. Verdejo-García A.J., López-Torrecillas F., Aguilar de Arcos F., Pérez-García M. Differential effects of MDMA, cocaine and cannabis use severity on distinctive components of the executive functions in polysubstance users: a multiple regression analysis. Addictive Behaviors 2005, 30:89-101.
62. Vita A., DePeri L., Barlati S., Cacciani P., Cisima M., Deste G., Cesana B.M., Sacchetti E. Psychopathologic, neuropsychological and functional outcome measures during cognitive rehabilitation in schizophrenia: a prospective controlled study in a real-world setting. European Psychiatry 2011, 26(5):276-283.
63. Vollenweider F.X., Barro M., Csomor P.A., Feldon J. Clozapine enhances prepulse inhibition in healthy humans with low but not with high prepulse inhibition levels. Biological Psychiatry 2006, 60:597-603.
64. Woznica A.A., Sacco K.A., George T.P. Prepulse inhibition deficits in schizophrenia are modified by smoking status. Schizophrenia Research 2009, 112(1-3):86-90.
65. Woznica A.A., Sacco K.A., George T.P. Prepulse inhibition deficits in schizophrenia are modified by smoking status. Schizophrenia Research 2009, 112:86-90.
66. Wykes T., Huddy V. Cognitive remediation for schizophrenia: it is even more complicated. Current Opinion in Psychiatry 2009, 22:161-167.
67. Wykes T., Reedder C., Landau S., Everitt B., Knapp M., Patel A., Romeo R. Cognitive remediation therapy in schizophrenia. The British Journal of Psychiatry 2007, 190:421-427.
68. Yip S.W., Sacco K.A., George T.P., Potenza M.N. Risk/reward decision-making in schizophrenia: a preliminary examination of the influence of tobacco smoking and relationship to Wisconsin Card Sorting Task performance. Schizophrenia Research 2009, 110(1-3):156-164.
69. Yücel M., Lubman D.I., Solowjim N., Brewer W.J. Understanding drug addiction: a neuropsychological perspective. The Australian and New Zealand Journal of Psychiatry 2007, 41:957-968.